NEXENTIS TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 76 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 49.00 shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 27.00 shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 37.00 shares, a 54.17% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 24.00 shares, a 99.60% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 6.01K shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 2.38K shares, a 91.89% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | 49.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 76.00 shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 27.00 shares 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 37.00 shares 10-K · filed 2026-03-31 | |||
| 2024-12-31 | 24.00 shares 10-K · filed 2026-03-31 | 817.00 shares 10-K · filed 2025-03-31 | ||
| 2023-12-31 | 6.01K shares 10-K · filed 2025-03-31 | |||
| 2021-12-31 | 2.38K shares 10-K · filed 2023-03-27 | |||
| 2020-12-31 | 29.36K shares 10-K · filed 2022-03-31 | |||
| 2019-12-31 | 4.76K shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |